| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0855c85f83426a0a19ca17ee2ef4b05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69af663728c81c64f34d360a37055cdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4baf9054105973c9e1334e376d60528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc0ec2fc5c3900389ea3395773f33a83 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1214 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 |
| filingDate |
2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac346849971638eb440e9fb6e091707c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e9864cc7062ce284ca193af526deb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2acc5b16fa1ed1f39aae4484af58be02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dddcd439fac1b9e9e76f7e3b7c8e1595 |
| publicationDate |
2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8501179-B2 |
| titleOfInvention |
Antibody against PcrV |
| abstract |
Provided is an effective means for therapy of infection, particularly infection with Pseudomonas aeruginosa. Provided are a monoclonal antibody against PcrV or a part thereof, and a pharmaceutical composition containing the same as an active ingredient. Concretely, monoclonal antibody of the present invention has excellent inhibiting activity on cytotoxicity with respect to a target cell of Pseudomonas aeruginosa. Also, the monoclonal antibody of the present invention has high affinity with PcrV. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11203633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10597439-B2 |
| priorityDate |
2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |